The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC)

He K, Cui B, Li G, Wang H, Jin K, Teng L

OncoTargets and Therapy 2012, 5:59-65

Published Date: 13 April 2012